Bloomberg Technology
@bloombergtech·728K subscribers·13.9K videos
Why Humacyte Is Going Public Via SPAC
Posted
February 17, 2021
Views
7,914
Likes
150
Comments
18
Engagement
2.12%
February 17, 2021
7,914
150
18
2.12%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
5:00Now PlayingFeb.17 -- Dr. Laura Niklason, chief executive officer and founder of Humacyte, discusses the biotech company's decision to go public through a merger with Alpha Healthcare Acquisition Corp., a special purpose acquisition company (SPAC). She speaks on "Bloomberg Markets: The Close."
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
